| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |